Pearl River Capital, LLC Beam Therapeutics Inc. Transaction History

Pearl River Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$23.46 - $45.07 $361,964 - $695,385	15,429 New	15,429 $509,000
Q1 2023 May 12, 2023	BUY	$30.15 - $48.79 $121,685 - $196,916	4,036 Added 37.93%	14,676 $449,000
Q4 2022 Feb 13, 2023	SELL	$36.73 - $51.6 $176,854 - $248,454	-4,815 Reduced 31.15%	10,640 $416,000
Q3 2022 Nov 14, 2022	SELL	$39.79 - $70.31 $100,310 - $177,251	-2,521 Reduced 14.02%	15,455 $736,000
Q2 2022 Aug 12, 2022	BUY	$29.86 - $62.36 $428,968 - $895,863	14,366 Added 397.95%	17,976 $696,000
Q1 2022 May 13, 2022	BUY	$53.73 - $82.16 $193,965 - $296,597	3,610 New	3,610 $207,000

236

75.2M

438K

232K

Ticker BEAM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,354,600
Market Cap $1.78B
Description
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...

Get notified when there are updates to the investment portfolio of Pearl River Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Pearl River Capital, LLC with notifications on news.